14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for EXEL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 22.77 3.98 %
R2 22.49 2.69 %
R1 22.32 1.90 %
Current price: 21.90
Support S1 21.75 -0.675 %
S2 21.58 -1.47 %
S3 21.30 -2.76 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 22.98 4.93 %
R2 22.87 4.43 %
R1 21.93 0.114 %
Current price 21.90
Support S1 20.39 -6.89%
S2 20.18 -7.85%
S3 20.17 -7.90%

EXEL Predictions History

4 years ago
2poJeff predicted that EXEL for 2020-02-28 is going $19.02 (3.26%)

5 years ago
Clement.Foo.105888 predicted that EXEL for 2019-04-22 is going $24.65 (17.94%)

Rank:

5 years ago
Clement.Foo.105888 predicted that EXEL for 2019-04-10 is going $24.45 (1.75%)

Rank:

5 years ago
JS predicted that EXEL for 2019-04-02 is going $24.48 (-1.01%)

5 years ago
PumpTheseNumbers predicted that EXEL for 2019-04-02 is going $24.53 (-0.81%)

5 years ago
JS predicted that EXEL for 2019-02-13 is going $21.79 (-1.18%)

5 years ago
JS predicted that EXEL for 2018-07-24 is going $21.44 (2.78%)

5 years ago
paoooolo predicted that EXEL for 2018-07-24 is going $21.50 (0.99%)

Rank:

6 years ago
Vladislav.Barrow.10350 predicted that EXEL for 2017-08-03 is going $17.62 (-31.47%)

Rank:

7 years ago
JS predicted that EXEL for 2017-04-10 is going $20.64 (1.78%)

Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT